Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Several systemic agents have been approved for use in advanced hepatocellular carcinoma (aHCC). However, it is unclear which treatment is superior in either the first- or second-line settings due to the paucity of head-to-head comparative trials. Therefore, we have conducted a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Robin, Lopes da Silva, Laercio, Nissaisorakarn, Voravech, Riano, Ivy, Williamson, Stephen, Sun, Weijing, Saeed, Anwaar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997949/
https://www.ncbi.nlm.nih.gov/pubmed/33791250
http://dx.doi.org/10.2147/JHC.S268305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997949/
https://www.ncbi.nlm.nih.gov/pubmed/33791250
http://dx.doi.org/10.2147/JHC.S268305

Ejemplares similares